2021 annual financial data

Alaunos Therapeutics 2021 Net margin

Alaunos Therapeutics 2021 net margin with verified reported values.

Direct answer

Net margin was -19,786.68%.

Operating income was -77,549,000 USD and net income was -78,751,000 USD.
Operating cash flow was -61,468,000 USD.

Get free Alaunos Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
398,000 USD
Operating income
-77,549,000 USD
Net income
-78,751,000 USD
Operating cash flow
-61,468,000 USD